萬春藥業

BYSI

全部股東

股東類型

  • 公眾及其他70.92%
  • 個人與內幕人士13.06%
  • 創投/私募9.24%
  • 機構投資者6.78%

主要股東

主要股東 最新
股東
Lan HuangCo-Founder & Chair of the Board
12.87%529.34 萬<0.01%-4.0030/06/2026
Decheng Capital LLC
9.24%380.07 萬0.00%+030/06/2026
Vanguard Capital Management, LLC
1.96%80.77 萬0.05%+1.98 萬30/06/2026
BlackRock, Inc.
1.64%67.29 萬0.06%+2.35 萬30/06/2026
Sincere Efforts Foundation Inc
1.20%49.45 萬0.00%+031/03/2026
Geode Capital Management, LLC
0.89%36.77 萬0.02%-7,631.0030/06/2026
State Street Investment Management
0.56%23.11 萬0.00%+030/06/2026
UBS Asset Management AG
0.15%6.30 萬0.15%+6.19 萬30/06/2026
Northern Trust Global Investments
0.15%6.20 萬0.02%-7,244.0030/06/2026
Jiangwen MajetiIndependent Vice Chairman
0.12%5.09 萬0.00%+027/02/2026
Tanaka Capital Management Inc
0.06%2.63 萬0.00%+031/03/2026
Patrick FabbioIndependent Director
0.06%2.46 萬0.00%+027/02/2026
Meridian Wealth Management, LLC
0.04%1.50 萬0.00%+030/06/2026
Farther Finance Advisors, LLC
0.03%1.28 萬--+1.28 萬30/06/2026
Renaissance Technologies LLC
0.03%1.09 萬<0.01%-200.0030/06/2026
Lord, Abbett & Co. LLC
0.02%7,272.00<0.01%+1,233.0030/06/2026
Vanguard Global Advisers, LLC
0.01%4,802.000.00%+030/06/2026
Morgan Stanley
<0.01%4,000.000.00%+030/06/2026
National Bank Investments Inc.
<0.01%2,875.000.00%+030/06/2026
Trifecta Capital Advisors, LLC
<0.01%1,500.000.00%+030/06/2026